This is a feasibility study intervention to fifty cancer patients with obesity and with newly diagnosed stage II-IV solid tumors undergoing curative treatment recruited at the Catalan Institute of Oncology (ICO) in L'Hospitalet, Spain. The investigators hypothesize that weight management during cancer treatment could enhance health outcomes for this population. The feasibility of a multimodal weight loss management program will be assesses, including a personalized hypocaloric and high-protein diet combined with a supervised exercise home-program and behavioural support.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Accrual
Timeframe: From baseline to end of cancer treatment (3 to 9 months)
Retention
Timeframe: From baseline to end of cancer treatment (3 to 9 months)
Fidelity of the programme delivery
Timeframe: From baseline to end of cancer treatment (3 to 9 months)
Nutritional adherence
Timeframe: From baseline to end of cancer treatment (3 to 9 months)
Physical activity adherence
Timeframe: From baseline to end of cancer treatment (3 to 9 months)
Ocurrance of any serious or life-threatening adverse events (Safety)
Timeframe: Throughout the study period (from baseline to end of intervention, 3 to 9 months)